2005
DOI: 10.1590/s0004-27302005000200003
|View full text |Cite
|
Sign up to set email alerts
|

Importância da avaliação da função tireoidiana em pacientes com diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
2

Year Published

2013
2013
2020
2020

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 6 publications
(15 reference statements)
0
6
0
2
Order By: Relevance
“…The effects of iodothyronine on the various metabolic pathways are assessed by specific tests, such as free T4, free T3 and TSH. 8,9,10,13 Studies comparing the incidence of specific thyroid dysfunction (TD) between type 1 and type 2 diabetic patients show different inferences i.e. general consensus is TD is more prevalent among patients with type 2 diabetes mellitus, although some studies show a greater prevalence in type 1 DM; with female prevalence higher than males, proportionate increment of TD with age of onset, longer duration of diabetes, poorer glycaemic control and with patients having relatively higher abnormal body mass index and other co-morbid states like cardiovascular diseases namely hypertension, atherosclerosis and obesity.…”
mentioning
confidence: 99%
“…The effects of iodothyronine on the various metabolic pathways are assessed by specific tests, such as free T4, free T3 and TSH. 8,9,10,13 Studies comparing the incidence of specific thyroid dysfunction (TD) between type 1 and type 2 diabetic patients show different inferences i.e. general consensus is TD is more prevalent among patients with type 2 diabetes mellitus, although some studies show a greater prevalence in type 1 DM; with female prevalence higher than males, proportionate increment of TD with age of onset, longer duration of diabetes, poorer glycaemic control and with patients having relatively higher abnormal body mass index and other co-morbid states like cardiovascular diseases namely hypertension, atherosclerosis and obesity.…”
mentioning
confidence: 99%
“…There is a great variability in the prevalence of Td in general population, ranging from 6.6% to 13.4%. 15 Screening of TD, especially the subclinical dysfunction, in patients with DM is justified because most patients can be asymptomatic. Determining the prevalence of clinical and subclinical thyroid disease in diabetic patients in our country and its implications in the course of diabetes and known factors for cardiovascular risk shall be an advantage in the management of type 2 DM.…”
Section: Discussionmentioning
confidence: 99%
“…Thyroid diseases are also common in the general population. There is a great difference in the prevalence of the thyroid diseases in the general population, ranging from 6.6% to 13.4% [3,4]. Large scale studies of thyroid dysfunction in the United States have reported prevalence of 6.6% in the general population [5,6].…”
Section: Introductionmentioning
confidence: 99%